Latest market price
87.03
+1.29+1.50%
OverviewShort InterestFilings
MIRMQT31Mirum Pharmaceuticals, Inc.·NASDAQ
87.03+1.50%

Latest SEC Filings

Form category
DescriptionFilingDocument
Nov 03, 202610-QQuarterly report
Nov 03, 20268-KCurrent report
Oct 26, 20268-KCurrent report
Oct 19, 20264Statement of changes in beneficial ownership
Oct 14, 20264Statement of changes in beneficial ownership
Oct 13, 20268-KCurrent report
Oct 06, 20264Statement of changes in beneficial ownership
Sep 28, 20268-KCurrent report
Sep 22, 20263Initial statement of beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 20264Statement of changes in beneficial ownership
Aug 11, 20264Statement of changes in beneficial ownership
Aug 06, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
#1 / 25 of 428
Page
▼
/ 18